Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC

Clinical trial NCT04069936 · TERMINATED

Trial details

NCT number: NCT04069936
Sponsor: WindMIL Therapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Lung Cancer Lung Cancer Metastatic Lung Cancer, Non-small Cell Non Small Cell Lung Cancer Metastatic NSCLC Non-small Cell Lung Cancer Non-small Cell Lung Cancer Metastatic

Start date: 2019-10-15
Primary completion: 2021-10-28
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.